NewTimeSpace News: On 27 August 2026, Shanghai Vision Star Media Co., Ltd. filed a listing application with HKEX, with SPDB International as sole sponsor; by 2025 revenue, the Company was the fifth largest integrated marketing service provider and the largest brand-IP content marketing service provider in China; revenue reached RMB 8.3718 billion in 2025 (CAGR of 15.8% from 2023), serving over 2,000 clients including 69 China Fortune 500 enterprises; the Company has built the "Xinghe AI Full-Link Workbench" with peak daily token usage of approximately 1.7 billion; no stock code has been assigned at the filing stage.
NewTimeSpace News: On 27 August 2026, SHEIN-W (00625.HK) closed its H-share IPO subscription at noon; as of 11:10 a.m., total margin funds reached approximately HKD 6.465 billion, with the public offering covered approximately 4.66 times based on a public offering size of HKD 1.386 billion; the company is offering 280 million H shares at HKD 47.600-49.500 per share, implying gross proceeds of HKD 13.328-13.860 billion, and is expected to list on 1 September 2026.
NewTimeSpace News: On 26 August 2026, Zenshine Pharmaceuticals (Nanjing) Group Co., Ltd. filed a listing application with HKEX, with CICC as sole sponsor; its core product, sebaloxavir marboxil tablets, an influenza virus PA endonuclease inhibitor, obtained NDA approval for adult influenza in July 2025 and for adolescents in June 2026, and was officially launched in October 2025; the company has a pipeline of six small-molecule drug assets, distributes in China through Jumpcan Pharmaceutical and is expanding into the MENA region with Cigalah Medpharm.
NewTimeSpace News: On 21 August 2026, Eaglerise Electric & Electronic (CHINA) Co., Ltd. re-submitted a listing application to the HKEX Main Board, with Guotai Junan International as the sole sponsor; as a global power equipment and solutions provider specializing in transformer equipment, the Company ranked second among Chinese suppliers in the global medium-voltage transformer market in 2025 (2.3% share), with MV products accounting for about 70% of revenue, and its new energy, data center and lighting power supply segments all rank among the top Chinese or global suppliers.
NewTimeSpace News: On 21 August 2026, Tyligand Bioscience Ltd. re-submitted a listing application to the HKEX Main Board, with CITIC SEC as the sole sponsor; the Company, founded in 2017, is a clinical-stage biopharmaceutical company focused on oncology, with core product TSN1611, an oral KRAS G12D inhibitor, in Phase 2 trials in the US and China; it has communicated with the FDA on the registrational Phase 3 MRCT and plans to seek NMPA approval for participation in China.
NewTimeSpace News: On 19 August 2026, according to HKEX disclosure, Direct Drive Tech Limited filed its listing application with CITIC Securities as the sole sponsor; the Company is a direct-drive technology robot company, ranking first in China's consumer robot direct-drive power module industry (61.1% share) and second in the two-wheeled-footed robot industry (18.6%) by 2025 revenue, with the D1 being the world's first commercially launched modular two-wheeled-footed robot.
NewTimeSpace News: On 17 August 2026, the Hong Kong listing application of Shenzhen Hongyeji Geotechnical Technology Co., Ltd. filed on 15 February 2026 has lapsed after exceeding the six-month validity period, with CEB International as the original sole sponsor; the Company is the largest non-state-owned geotechnical engineering enterprise in South China and ranks first among non-state-owned enterprises participating in large-scale South China projects by 2024 revenue.
NewTimeSpace News: On 15 August 2026, ASR (688220.SH) announced that its board of directors approved on 13 August 2026 the resolution to issue H-shares and list on the Main Board of the Hong Kong Stock Exchange, aiming to advance its internationalization strategy; the offering and listing remains subject to shareholders' meeting approval and filings and approvals from the CSRC, HKEX and the SFC, with significant uncertainty as to whether it will be ultimately implemented.
NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to Shenzhen Inovance Technology for its overseas listing, requiring the Company to explain the business content of its overseas subsidiaries and the performance of outbound investment and foreign exchange registration procedures with a conclusive opinion on compliance, and to explain in detail the use of proceeds, whether it involves outbound investment and the status of relevant approvals, with a commitment to transfer all proceeds back to Mainland China if such procedures are incomplete.
NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to Suzhou Canmax Technologies for its overseas listing, requiring supplementary explanations and legal opinions on 6 items including whether the fund-raising projects are "high energy consumption" or "high emission" projects, the fairness of related-party transactions with CATL, pending litigation and arbitration, and the necessity of the Hong Kong listing.
NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to YESMRO Holdings Limited for its overseas listing, requiring supplementary explanations and legal opinions on 8 items including round-trip M&A compliance, new shareholders within the last 12 months, control identification, shareholder look-through and nominee shareholding, and equity incentives; the regulator specifically requires verification of the share repurchase and transfer in January 2026, the look-through of 5% shareholder Shanghai Lingyi and historical nominee shareholding arrangements.
NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to Ruike Xianjin for its overseas listing, requiring supplementary explanations and legal opinions on 7 items including round-trip M&A compliance, the restructuring progress of Ruihua Xindian, joint actual controller determination, nominee shareholding and equity incentives.
NewTimeSpace News: On 17 August 2026, Mech-Mind Robotics Technologies Co., Ltd. announced that it had passed the HKEX listing hearing on 16 August 2026, with CSC International and CITIC Securities as joint sponsors; the Company is a 3D-vision-and-AI driven smart robotics component supplier whose products have been sold in nearly 50 countries and regions worldwide.
NewTimeSpace News: The CSRC has issued an overseas listing filing notice, pursuant to which Hunan Junxin Environmental Protection Co., Ltd. plans to issue no more than 221,434,400 overseas listed ordinary shares and list on the HKEX.
NewTimeSpace News: VivaVision Biotech (Zhejiang) Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; CICC acted as the original sole sponsor. Both core products have initiated Phase III clinical trials in China: VVN461 (high dose), a novel JAK1/TYK2 dual-target inhibitor for non-infectious anterior uveitis, and VVN001, a second-generation LFA-1 antagonist for dry eye disease; the Company plans to submit an IND amendment in Q2 2026 and initiate VVN461 (high dose) Phase III in the US by the end of 2026.
NewTimeSpace News: Shenzhen Immunofoco Biotechnology Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; Huatai International acted as the original sole sponsor. Core product IMC002, a potentially best-in-class anti-CLDN18.2 CAR-T cell therapy candidate ranking second globally in clinical progress, is in pivotal Phase III; the global CAR-T cell therapy market is expected to grow from USD 4.7 billion in 2024 to USD 35.2 billion in 2035.
